Results for tag: "Gefitinib"

Gefitinib is a type of lung cancer drug, also known as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Gefitinib works by blocking the action of the EGFR, which is a protein that helps cancer cells grow and divide. This helps to slow down the growth of the cancer cells and can even shrink the tumor. Gefitinib is usually taken as a pill once a day and is usually used in combination with other cancer treatments. Gefitinib is a relatively new drug and is still being studied to determine its effectiveness in treating NSCLC. It is approved for use in some countries, but not all. It is also not approved for use in all types of NSCLC. Some companies in the Gefitinib market include AstraZeneca, Pfizer, and Novartis. Show Less Read more